C4 Therapeutics (CCCC) Operating Leases (2019 - 2026)
C4 Therapeutics' Operating Leases came in at $50.18 million for Q2 2026, down 11.7% from $56.86 million a year earlier and down 3.4% from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, C4 Therapeutics' Operating Leases was $53.62 million, down 10.6% from FY2024.
- Operating Leases has declined in each of the last three years, though with a five-year compound annual growth rate of 35.3% (FY2020 to FY2025).
- Going back by year, Operating Leases was $59.98 million in FY2024 (-8.8%), $65.76 million in FY2023 (-7.3%), $70.97 million in FY2022 (+130.6%) and $30.78 million in FY2021 (+160.2%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q4 2021.
- Year-over-year, Operating Leases has declined for 14 consecutive quarters, with an average decline of 10.0% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q3 2022 (growth of 561.0%), and the weakest in Q2 2026 (a decline of 11.7%).
- Business Quant data shows CCCC's Operating Leases at $51.93 million (Q1 2026), $53.62 million (Q4 2025) and $55.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | C4 Therapeutics | 413.66 Mn | -516.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.18 Mn |
| Mar 31, 2026 | 51.93 Mn |
| Dec 31, 2025 | 53.62 Mn |
| Sep 30, 2025 | 55.25 Mn |
| Jun 30, 2025 | 56.86 Mn |
| Mar 31, 2025 | 58.45 Mn |
| Dec 31, 2024 | 59.98 Mn |
| Sep 30, 2024 | 61.46 Mn |
| Jun 30, 2024 | 62.92 Mn |
| Mar 31, 2024 | 64.37 Mn |
| Dec 31, 2023 | 65.76 Mn |
| Sep 30, 2023 | 67.10 Mn |
| Jun 30, 2023 | 68.42 Mn |
| Mar 31, 2023 | 69.72 Mn |
| Dec 31, 2022 | 70.97 Mn |
| Sep 30, 2022 | 72.18 Mn |
| Jun 30, 2022 | 73.37 Mn |
| Mar 31, 2022 | 74.75 Mn |
| Dec 31, 2021 | 30.78 Mn |
| Sep 30, 2021 | 10.92 Mn |
API Access
C4 Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();